Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer

Breast Cancer ◽

10.1007/s12282-013-0483-1 ◽

2013 ◽

Vol 22 (4) ◽

pp. 335-342 ◽

Author(s):

Hiroko Otsuka ◽

Teruhiko Fujii ◽

Uhi Toh ◽

Nobutaka Iwakuma ◽

Ryuji Takahashi ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Metronomic Chemotherapy ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Recurrent Breast

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

1848 Phase II clinical trial of metronomic oral capecitabine therapy combined with aromatase inhibitors in postmenopausal metastatic and recurrent breast cancer resistant to first-line aromatase inhibitors

European Journal of Cancer ◽

10.1016/s0959-8049(16)30798-5 ◽

2015 ◽

Vol 51 ◽

pp. S281 ◽

Author(s):

L. Jian-wei ◽

J. Xiao-qing ◽

L. Li ◽

W. Yu-jie ◽

S. Zhi-min ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Aromatase Inhibitors ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Oral Capecitabine ◽

Recurrent Breast

Download Full-text

KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03946202 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Locally Advanced ◽

Recurrent Breast Cancer ◽

Radiation Sensitizer ◽

Recurrent Breast

Download Full-text

Abstract P4-01-03: HDACi (vorinostat) in metastatic breast cancer to restore sensitivity to ER-directed (AI) therapy: A phase II clinical trial with FES imaging correlates

10.1158/0008-5472.sabcs13-p4-01-03 ◽

2013 ◽

Author(s):

HM Linden ◽

BF Kurland ◽

JM Link ◽

A Novakova ◽

X Chai ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial

Download Full-text

Abstract P1-14-06: Everolimus effect on hematologic parameters in a phase II clinical trial for metastatic estrogen receptor (ER) positive breast cancer

10.1158/0008-5472.sabcs13-p1-14-06 ◽

2013 ◽

Author(s):

A Chen ◽

L Chen ◽

E Romond ◽

V Kadamyan ◽

M Stevens ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Estrogen Receptor ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Er Positive ◽

Positive Breast Cancer

Download Full-text

Abstract OT1-05-02: A phase II clinical trial of the combination of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor positive triple negative breast cancer

10.1158/1538-7445.sabcs17-ot1-05-02 ◽

2018 ◽

Author(s):

Y Yuan ◽

P Frankel ◽

T Synold ◽

P Lee ◽

S Yost ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Androgen Receptor ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Clinical Trial ◽

Selective Androgen Receptor Modulator ◽

Receptor Modulator

Download Full-text

A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05928-4 ◽

2020 ◽

Author(s):

Otto Metzger Filho ◽

Anita Giobbie-Hurder ◽

Nancy U. Lin ◽

Meredith Faggen ◽

Steven Come ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Adverse Events ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Breast Cancer Patients

Download Full-text

A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer

Tumori Journal ◽

10.1177/030089168807400109 ◽

1988 ◽

Vol 74 (1) ◽

pp. 53-56 ◽

Author(s):

Tiping Zhao ◽

Guifen He

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Transient Response ◽

Postmenopausal Breast Cancer ◽

Phase Ii Clinical Trial ◽

Advanced Breast ◽

Breast Cancer Patients

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

Download Full-text

Cardiac MRI for Evaluation of Radiation-Induced Cardiotoxicity in Breast Cancer Patients: A Phase II Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.2398 ◽

2019 ◽

Vol 105 (1) ◽

pp. E59-E60

Author(s):

C. Speers ◽

V.L. Murthy ◽

E.M. Walker ◽

E. Morris ◽

C. Glide-Hurst ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Cardiac Mri ◽

Phase Ii Clinical Trial ◽

Breast Cancer Patients ◽

Radiation Induced

Download Full-text

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer

Cancer Biology & Therapy ◽

10.1080/15384047.2015.1026481 ◽

2015 ◽

Vol 16 (5) ◽

pp. 678-683 ◽

Author(s):

S Cowherd ◽

L D Miller ◽

S A Melin ◽

S Akman ◽

S Isom ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel

Download Full-text